ArticleFrontiers in medicine2026

Sequential CDK4/6 inhibition in bone-only metastatic HR+/HER2- breast cancer: a case of prolonged disease control with abemaciclib after clinical progression on palbociclib-based therapy.

Xuejiao Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.